Comorbidity defines asthmatic patients' risk of COVID-19 hospitalization: A global perspective

Chrysanthi Skevaki1, R Sharon Chinthrajah2, Daria Fomina3

  • 1Institute of Laboratory Medicine and Pathobiochemistry, Philipps University Marburg, Marburg, Germany; Universities of Giessen and Marburg Lung Center (UGMLC), Philipps University Marburg, Marburg, Germany.

Insights

Asthma prevalence varied significantly in hospitalized coronavirus disease 2019 (COVID-19) patients globally. Geographic differences in asthma and COVID-19 co-occurrence are linked to varying comorbidity prevalence, especially chronic obstructive pulmonary disease.

Area of Science:

  • Epidemiology
  • Pulmonology
  • Infectious Diseases

Background:

  • Global epidemiology of asthma in COVID-19 patients shows significant geographic variations.
  • Prevalence zones of high and low co-occurrence of asthma and COVID-19 are defined.

Purpose of the Study:

  • To compare asthma prevalence in hospitalized COVID-19 patients across major global hubs.
  • To apply common inclusion criteria and definitions for accurate comparison.

Main Methods:

  • A network of 6 academic hospitals was established in the United States, Germany, and Russia.
  • Clinical and laboratory data were collected for patients hospitalized with COVID-19.

Main Results:

  • Asthmatic patients were overrepresented in the US (Stanford) and underrepresented in Russia (Moscow) and Germany compared to local community prevalence.
  • Asthma prevalence did not differ between intensive care unit and non-intensive care unit patients, suggesting no increased risk for severe COVID-19.
  • Comorbidities, particularly chronic obstructive pulmonary disease, were more frequent in asthmatic COVID-19 patients in the US cohort.

Conclusions:

  • Disparities in COVID-19-associated risk among asthmatic patients are linked to geographic variations in underlying comorbidities.
  • Chronic obstructive pulmonary disease prevalence significantly influences the observed differences in asthma and COVID-19 co-occurrence globally.
Abstract

Related Concept Videos

Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.6K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
520
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
3.2K